-
1
-
-
0037032835
-
The protein kinase complement of the human genome
-
DOI 10.1126/science.1075762
-
Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome Science 2002, 298, 1912-1934 (Pubitemid 35425239)
-
(2002)
Science
, vol.298
, Issue.5600
, pp. 1912-1934
-
-
Manning, G.1
Whyte, D.B.2
Martinez, R.3
Hunter, T.4
Sudarsanam, S.5
-
2
-
-
0032577051
-
The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease
-
DOI 10.1098/rstb.1998.0228
-
Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease Philos. Trans. R. Soc., B 1998, 353, 583-605 (Pubitemid 28314105)
-
(1998)
Philosophical Transactions of the Royal Society B: Biological Sciences
, vol.353
, Issue.1368
, pp. 583-605
-
-
Hunter, T.1
-
3
-
-
80053576891
-
Protein kinase biochemistry and drug discovery
-
Schwartz, P. A.; Murray, B. W. Protein kinase biochemistry and drug discovery Bioorg. Chem. 2011, 39, 192-210
-
(2011)
Bioorg. Chem.
, vol.39
, pp. 192-210
-
-
Schwartz, P.A.1
Murray, B.W.2
-
4
-
-
0035902180
-
Oncogenic kinase signalling
-
DOI 10.1038/35077225
-
Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling Nature 2001, 411, 355-365 (Pubitemid 32467045)
-
(2001)
Nature
, vol.411
, Issue.6835
, pp. 355-365
-
-
Blume-Jensen, P.1
Hunter, T.2
-
5
-
-
0032524350
-
Autoregulatory mechanisms in protein-tyrosine kinases
-
DOI 10.1074/jbc.273.20.11987
-
Hubbard, S. R.; Mohammadi, M.; Schlessinger, J. Autoregulatory mechanisms in protein-tyrosine kinases J. Biol. Chem. 1998, 273, 11987-11990 (Pubitemid 28240552)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.20
, pp. 11987-11990
-
-
Hubbard, S.R.1
Mohammadi, M.2
Schlessinger, J.3
-
6
-
-
0037469146
-
Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model?
-
DOI 10.1021/bi020617o
-
Adams, J. A. Activation Loop Phosphorylation and Catalysis in Protein Kinases: Is There Functional Evidence for the Autoinhibitor Model? Biochemistry 2002, 42, 601-607 (Pubitemid 36133283)
-
(2003)
Biochemistry
, vol.42
, Issue.3
, pp. 601-607
-
-
Adams, J.A.1
-
7
-
-
18344395134
-
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
-
DOI 10.1038/nsb770
-
Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.; Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Nat. Struct. Biol. 2002, 9, 268-272 (Pubitemid 34289898)
-
(2002)
Nature Structural Biology
, vol.9
, Issue.4
, pp. 268-272
-
-
Pargellis, C.1
Tong, L.2
Churchill, L.3
Cirillo, P.F.4
Gilmore, T.5
Graham, A.G.6
Grob, P.M.7
Hickey, E.R.8
Moss, N.9
Pav, S.10
Regan, J.11
-
8
-
-
79952096135
-
Biochemical Characterization of TAK-593, a Novel VEGFR/PDGFR Inhibitor with a Two-Step Slow Binding Mechanism
-
Iwata, H.; Imamura, S.; Hori, A.; Hixon, M. S.; Kimura, H.; Miki, H. Biochemical Characterization of TAK-593, a Novel VEGFR/PDGFR Inhibitor with a Two-Step Slow Binding Mechanism Biochemistry 2011, 50, 738-751
-
(2011)
Biochemistry
, vol.50
, pp. 738-751
-
-
Iwata, H.1
Imamura, S.2
Hori, A.3
Hixon, M.S.4
Kimura, H.5
Miki, H.6
-
9
-
-
33846899405
-
Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors
-
DOI 10.1021/jm0608107
-
Liao, J. J.-L. Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors J. Med. Chem. 2007, 50, 409-424 (Pubitemid 46239775)
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, Issue.3
, pp. 409-424
-
-
Liao, J.J.-L.1
-
10
-
-
33745298429
-
Rational design of inhibitors that bind to inactive kinase conformations
-
DOI 10.1038/nchembio799, PII N799
-
Liu, Y.; Gray, N. S. Rational design of inhibitors that bind to inactive kinase conformations Nat. Chem. Biol. 2006, 2, 358-364 (Pubitemid 43936934)
-
(2006)
Nature Chemical Biology
, vol.2
, Issue.7
, pp. 358-364
-
-
Liu, Y.1
Gray, N.S.2
-
11
-
-
4344592378
-
Fragment-based lead discovery
-
Rees, D. C.; Congreve, M.; Murray, C. W.; Carr, R. Fragment-based lead discovery Nat. Rev. Drug Dicovery 2004, 3, 660-672 (Pubitemid 39173507)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.8
, pp. 660-672
-
-
Ress, D.C.1
Congreve, M.2
Murray, C.W.3
Carr, R.4
-
12
-
-
0141726877
-
A 'Rule of Three' for fragment-based lead discovery?
-
DOI 10.1016/S1359-6446(03)02831-9, PII S1359644603028319
-
Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A 'Rule of Three' for fragment-based lead discovery? Drug Discovery Today 2003, 8, 876-877 (Pubitemid 37194496)
-
(2003)
Drug Discovery Today
, vol.8
, Issue.19
, pp. 876-877
-
-
Congreve, M.1
Carr, R.2
Murray, C.3
Jhoti, H.4
-
13
-
-
46849089254
-
Recent developments in fragment-based drug discovery
-
DOI 10.1021/jm8000373
-
Congreve, M.; Chessari, G.; Tisi, D.; Woodhead, A. J. Recent developments in fragment-based drug discovery J. Med. Chem. 2008, 51, 3661-3680 (Pubitemid 351956496)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.13
, pp. 3661-3680
-
-
Congreve, M.1
Chessari, G.2
Tisi, D.3
Woodhead, A.J.4
-
14
-
-
52049123291
-
Do enthalpy and entropy distinguish first in class from best in class?
-
Freire, E. Do enthalpy and entropy distinguish first in class from best in class? Drug Discovery Today 2008, 13, 869-874
-
(2008)
Drug Discovery Today
, vol.13
, pp. 869-874
-
-
Freire, E.1
-
15
-
-
67649494337
-
Transforming fragments into candidates: Small becomes big in medicinal chemistry
-
de Kloe, G. E.; Bailey, D.; Leurs, R.; de Esch, I. J. Transforming fragments into candidates: Small becomes big in medicinal chemistry Drug Discovery Today 2009, 14, 630-646
-
(2009)
Drug Discovery Today
, vol.14
, pp. 630-646
-
-
De Kloe, G.E.1
Bailey, D.2
Leurs, R.3
De Esch, I.J.4
-
16
-
-
52049086906
-
Kinase array design, back to front: Biaryl amides
-
Baldwin, I.; Bamborough, P.; Haslam, C. G.; Hunjan, S. S.; Longstaff, T.; Mooney, C. J.; Patel, S.; Quinn, J.; Somers, D. O. Kinase array design, back to front: Biaryl amides Bioorg. Med. Chem. Lett. 2008, 18, 5285-5289
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 5285-5289
-
-
Baldwin, I.1
Bamborough, P.2
Haslam, C.G.3
Hunjan, S.S.4
Longstaff, T.5
Mooney, C.J.6
Patel, S.7
Quinn, J.8
Somers, D.O.9
-
17
-
-
77954127254
-
The 'retro-design' concept for novel kinase inhibitors
-
Müller, G.; Sennhenn, P. C.; Woodcock, T.; Neumann, L. The 'retro-design' concept for novel kinase inhibitors IDrugs 2010, 13, 457-466
-
(2010)
IDrugs
, vol.13
, pp. 457-466
-
-
Müller, G.1
Sennhenn, P.C.2
Woodcock, T.3
Neumann, L.4
-
18
-
-
67349094019
-
A new screening assay for allosteric inhibitors of cSrc
-
Simard, J. R.; Kluter, S.; Grutter, C.; Getlik, M.; Rabiller, M.; Rode, H. B.; Rauh, D. A new screening assay for allosteric inhibitors of cSrc Nat. Chem. Biol. 2009, 5, 394-396
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 394-396
-
-
Simard, J.R.1
Kluter, S.2
Grutter, C.3
Getlik, M.4
Rabiller, M.5
Rode, H.B.6
Rauh, D.7
-
19
-
-
67649995940
-
Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors
-
Simard, J. R.; Getlik, M.; Grutter, C.; Pawar, V.; Wulfert, S.; Rabiller, M.; Rauh, D. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors J. Am. Chem. Soc. 2009, 131, 13286-13296
-
(2009)
J. Am. Chem. Soc.
, vol.131
, pp. 13286-13296
-
-
Simard, J.R.1
Getlik, M.2
Grutter, C.3
Pawar, V.4
Wulfert, S.5
Rabiller, M.6
Rauh, D.7
-
20
-
-
80052579653
-
Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: Comparison of binding to non-phosphorylated and phosphorylated VEGFR2
-
Iwata, H.; Imamura, S.; Hori, A.; Hixon, M. S.; Kimura, H.; Miki, H. Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: Comparison of binding to non-phosphorylated and phosphorylated VEGFR2 Bioorg. Med. Chem. 2011, 19, 5342-5351
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 5342-5351
-
-
Iwata, H.1
Imamura, S.2
Hori, A.3
Hixon, M.S.4
Kimura, H.5
Miki, H.6
-
21
-
-
0000957077
-
Studies on liver alcohol dehydrogenase complexes: III. Multiple inhibition kinetics in the presence of two competitive inhibitors
-
Yonetani, T.; Theorell, H. Studies on liver alcohol dehydrogenase complexes: III. Multiple inhibition kinetics in the presence of two competitive inhibitors Arch. Biochem. Biophys. 1964, 106, 243-251
-
(1964)
Arch. Biochem. Biophys.
, vol.106
, pp. 243-251
-
-
Yonetani, T.1
Theorell, H.2
-
22
-
-
0020346411
-
The Yonetani-Theorell graphical method for examining overlapping subsites of enzyme active centers
-
Yonetani, T. The Yonetani-Theorell graphical method for examining overlapping subsites of enzyme active centers Methods Enzymol. 1982, 87, 500-509
-
(1982)
Methods Enzymol.
, vol.87
, pp. 500-509
-
-
Yonetani, T.1
-
23
-
-
77957595999
-
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d] pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation
-
Oguro, Y.; Miyamoto, N.; Okada, K.; Takagi, T.; Iwata, H.; Awazu, Y.; Miki, H.; Hori, A.; Kamiyama, K.; Imamura, S. Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation Bioorg. Med. Chem. 2010, 18, 7260-7273
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 7260-7273
-
-
Oguro, Y.1
Miyamoto, N.2
Okada, K.3
Takagi, T.4
Iwata, H.5
Awazu, Y.6
Miki, H.7
Hori, A.8
Kamiyama, K.9
Imamura, S.10
|